Answers are grounded in this paper and cite their sources.
Observational analysis uncovers high diagnostic accuracy for nPAX5 in B-cell acute lymphoblastic leukemia, suggesting immediate clinical adoption.
Flow cytometric nuclear PAX5 (nPAX5) demonstrated 100 % agreement with IHC and exhibited excellent diagnostic accuracy (AUC 0.955, 91.06 % sensitivity). These compelling results validate nPAX5 as a reliable and powerful FCM marker, supporting its immediate adoption for rapid and efficient B-lineage assignment in acute leukemia diagnostics.
No takes yet. Share an insight, caveat, or question.
Pootrakul et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: